Esteban Astiazaran Symonds, MD

Description

I am committed to treat each patient and their families with compassion and provide the best individualized care. My philosophy is to build a trusting relationship with my patients and their families, in which we can all be part of the decision-making process.

Keywords braf v600e v600k mutations, vkorc1 mutation, her2 positive breast cancer, genetic cancer risk assessment, rps20 gene, rnf43 gene, vhl gene, tmem127 gene, sufu gene, smarcb1 gene, smarca4 gene, smad4 gene, sdhd gene, sdhc gene, sdhb gene, sdhaf2 gene, sdha gene, rb1 gene, rad51d gene, rad51c gene, rad50 gene, ptch1 gene, pole gene, pold1 gene, pms2 gene, pdgfra gene, nthl1 gene, nbn gene, mutyh gene, msh6 gene, msh3 gene, msh2 gene, mre11a gene, mlh1 gene, max gene, mitf gene, met gene, kit gene, hoxb13 gene, grem1 gene, galnt12 gene, cdk4 gene, flcn gene, epcam gene, dicer1 gene, cdkn2a gene, cdh13 gene, bmpr1a gene, bard1 gene, bap1 gene, axin2 gene, apc gene, hereditary cancer gene panel, genetic testing ovarian cancer, genetic testing colon cancer, pten hamartoma tumor syndrome, hereditary diffuse gastric cancer syndrome, hereditary leiomyomatosis and renal cell carcinoma, hereditary paraganglioma pheochromocytoma, hereditary renal cell carcinoma, hereditary melanoma, palb2, atm mutation, pten, p53, checkpoint kinase 2, cancer syndromes, panel genetic testing, cancer genetics, family history of genetic disease carrier, genetic testing, hereditary breast and ovarian cancer, hereditary cancer risk, kras mutation, genetic counseling, breast cancer genetics, breast cancer genetic testing.